JMI Hospital Requisite Manufacturing Limited announcements
103 Dhaka Stock Exchange announcements for JMI Hospital Requisite Manufacturing Limited (JHRML) since 2022: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2023 (18).
- Alpha Credit Rating Limited has assigned surveillance rating of the Company as \"A+\" in the long term and \"ST-2\" in t
Alpha Credit Rating Limited has assigned surveillance rating of the Company as \"A+\" in the long term and \"ST-2\" in the short term along with Stable outlook based on audited financial statements as on June 30, 2023 and relevant qualitative information till December 25, 2023.
- Resumption after Record Date
Trading of the shares of the company will resume on 27.11.2023.
- Suspension for Record date
Trading of the shares of the company will remain suspended on record date i.e., 26.11.2023.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 22.11.2023 to 23.11.2023 and trading of the shares will remain suspended on record date i.e., 26.11.2023.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.54 for July-September 2023 as against Tk. 0.53 for July-September 2022; NOCFPS was Tk. 0.12 for July-September 2023 as against Tk. 0.91 for July-September 2022. NAV per share was Tk. 32.66 as on September 30, 2023 and Tk. 32.12 as on June 30, 2023.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 08, 2023 at 2:45 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2023.
- The auditor of the company has given the \"Emphasis of Matter\" paragraph in the Auditor\'s Report of the company for th
The auditor of the company has given the \"Emphasis of Matter\" paragraph in the Auditor\'s Report of the company for the year ended June 30, 2023. To view the details, please visit: https://www.dsebd.org/assets/pdf/EmpJMI_HOSPITAL_REQUISITE_MANUFACTURING_LTD30June2023.pdf
- The Board of Directors has recommended 5\% Cash Dividend for the year ended June 30, 2023. Date of AGM: 22.01.2024, Time
The Board of Directors has recommended 5\% Cash Dividend for the year ended June 30, 2023. Date of AGM: 22.01.2024, Time: 11:00 AM, Venue: Digital Platform. Record Date: 26.11.2023. The Company has also reported EPS of Tk. 2.41, NAV per share of Tk. 32.12 and NOCFPS of Tk. 3.70 for the year ended June 30, 2023 as against Tk. 3.25, Tk. 38.84 and Tk. 4.26 respectively for the year ended June 30, 2022. (cont.)
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (19.10.2023) following its corporate declaration. However, the floor price shall be applicable accordingly.
- Dividend Declaration and Revision of the use of IPO Proceeds
(Continuation news of JHRML): The Board of Directors of the company has also approved and recommended to revise the use of IPO proceeds, due to Covid-19, dollar crisis, Russia-Ukraine war, interruption in opening L/C and adding new component of machinery as well as new machinery lines subject to the approval of shareholders in the upcoming 15th AGM and Bangladesh Securities and Exchange Commission. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 18, 2023 at 5:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2023.
- The company has informed that the Board of Directors of the Company has decided to form a new subsidiary company under t
The company has informed that the Board of Directors of the Company has decided to form a new subsidiary company under the title of \"JMI Specialized Hospital Limited\" having its authorized capital of BDT 50 (Fifty) Crore and a paid up capital of BDT 20 (Twenty) Crore wherein the Company shall hold 65\% shares subject to the approval of concerned authorities.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.54 for January-March 2023 as against Tk. 1.60 for January-March 2022; EPS was Tk. 1.59 for July 2022-March 2023 as against Tk. 2.89 for July 2021-March 2022. NOCFPS was Tk. 2.16 for July 2022-March 2023 as against Tk. 2.38 for July 2021-March 2022. NAV per share was Tk. 31.29 as on March 31, 2023 and Tk. 38.84 as on June 30, 2022.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 30, 2023 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2023.
- Dividend Disbursement
The Company has informed that it has disbursed the cash dividend for the year ended June 30, 2022 to the respective shareholders.
- Category Change
The Company will be placed in 'A' category from existing 'N' category with effect from February 22, 2023 as the Company has reported disbursement of 12.50% cash dividend for the year ended June 30, 2022.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.52 for October-December 2022 as against Tk. 0.66 for October-December 2021; EPS was Tk. 1.05 for July-December 2022 as against Tk. 1.29 for July-December 2021. NOCFPS was Tk. 0.98 for July-December 2022 as against Tk. 1.93 for July-December 2021. NAV per share was Tk. 32.00 as on December 31, 2022 and Tk. 38.84 as on June 30, 2022.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2023 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2022.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.